VALIANT ORGANICS LIMITED is a Chemicals & Petrochemicals company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 1,153 | 1,052 | 723 | 719 | 739 |
| EBITDA (ex other income) | 205 | 169 | 35 | 54 | 94 |
| margin % | 17.8 | 16.1 | 4.8 | 7.5 | 12.7 |
| Owners' profit | 113 | 88 | (8) | (4) | 33 |
| EPS, as reported (₹) | 41.72 | 32.45 | (3.07) | (1.24) | 11.86 |
| ROE % · ROCE % | 19.7 · 23.3 | 13.9 · 17.5 | (1.2) · 1.1 | (0.5) · 3.3 | 4.4 · 7.0 |
| Debt / equity (x) | 0.56 | 0.37 | 0.35 | 0.34 | 0.33 |
| Cash from operations | (32) | 238 | 84 | 56 | 92 |
| Capex | (121) | (136) | (74) | (31) | (34) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 160 | 187 | 204 | 204 | 157 | 159 | 218 | 232 |
| Profit before tax | (12) | 6 | 7 | 10 | 7 | 8 | 17 | 30 |
| Net profit | (12) | 5 | 4 | 8 | 6 | 4 | 16 | 29 |
| EPS (₹) | (4.52) | 1.08 | 1.52 | 2.93 | 2.02 | 1.30 | 5.61 | 10.44 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Speciality Chemical Division | 169 | 77.8 |
| Pharma Division | 48 | 22.2 |
| Total, before eliminations | 218 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| PIDILITE INDUSTRIES LTD | 1,59,479 | 60.2 | 14.43 | 42.3 | 22.4 | 28.0 | 14.9 | 28.6 |
| SRF LTD | 73,583 | 34.0 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 7 Sept 2026 · Newspaper publication confirming 21st AGM notice and Annual Report dispatch | compliance | minimal | — | — |
| 5 Sept 2026 · Valiant Organics files BRSR for FY26 with key ESG disclosures | compliance | low | — | — |
| 5 Sept 2026 · Notice of 21st AGM on September 29, 2026 with FY26 Annual Report | board shareholder meetings | low | — | — |
| 5 Sept 2026 · Annual Report FY 2025-26 and 21st AGM Notice | results | high | — | — |
| 2 Sept 2026 · 21st AGM notice published; meeting on Sept 29 via video conferencing | compliance | minimal | — | — |
| 21 Aug 2026 · Q1-FY27 Investors Presentation: Revenue Up 14% YoY, EBITDA Margin at 17.97% | investor communications | medium | — | — |
| 14 Aug 2026 · Valiant Organics Q1 FY27 results published; unclaimed dividend to IEPF | compliance | minimal | — | — |
| 14 Aug 2026 · Q1 FY27 results in newspaper, unclaimed dividend IEPF transfer notice | compliance | minimal | — | — |
| 12 Aug 2026 · Valiant Organics grants 18,000 ESOP options at Rs 10 each | capital market events | low | — | — |
| 12 Aug 2026 · Q1 FY27 results: net profit up about 188% YoY, MD reappointed | business updates | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| 5.24 |
| 22.7 |
| 13.1 |
| 13.1 |
| 13.4 |
| 25.2 |
| GUJARAT FLUOROCHEM LTD | 52,514 | 85.7 | 6.64 | 41.5 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,836 | 55.4 | 11.03 | 39.5 | 16.7 | 16.4 | 23.0 | 37.5 |
| AETHER INDUSTRIES LIMITED | 22,229 | 94.3 | 9.05 | 60.4 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 21,769 | 27.8 | 3.71 | 22.4 | 9.4 | 10.2 | 12.6 | 21.5 |
| ATUL LTD | 18,401 | 23.1 | 2.92 | 14.9 | 10.9 | 13.3 | 10.9 | 23.1 |
| AARTI INDUSTRIES LTD | 17,846 | 33.6 | 3.00 | 18.8 | 7.0 | 4.4 | 13.0 | 16.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 20.5 | 23.4 | 42 of 103 | 60% |
| P/B | 1.5 | 2.9 | 23 of 99 | 78% |
| ROCE | 4.9 | 10.3 | 77 of 108 | 29% |
| ROE | 4.4 | 8.1 | 76 of 101 | 25% |
| Debt / Equity | 0.3 | 0.2 | 71 of 101 | 30% |
| EBITDA margin | 19.4 | 15.5 | 38 of 99 | 62% |
| Revenue growth | 13.3 | 24.4 | 71 of 94 | 25% |
| Profit growth | 256.8 | 55.1 | 13 of 92 | 87% |
| Market cap | 1111 | 732 | 46 of 107 | 58% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
